舍尼通联合哈乐治疗慢性非细菌性前列腺炎的临床观察

• 作 者: 应文群
• 机 构: 昆山市第一人民医院泌尿外科,
• 出 处: 中国实用医药
• 发表日期: 2010年28期
• 关键词: 慢性非细菌性前列腺炎 舍尼通 哈乐

目的评价舍尼通联合哈乐治疗慢性非细菌性前列腺炎的疗效。方法对46例慢性非细菌性前列腺炎进行4周的观察。口服舍尼通片1片,1日2次;哈乐(盐酸坦索罗辛)胶囊每晚1次,每次1粒。结果治疗4周后总有效率91.3%。全组病例观察过程中未发现任何药物不良反应。结论舍尼通联合哈乐治疗慢性非细菌性前列腺炎的疗效确切,耐受性良好。

Objective To evaluate the efficacy of Senetix combined with Halon in the treatment of chronic nonbacterial prostatitis. Methods 46 cases of chronic non-bacterial prostatitis were observed for 4 weeks. Oral ciclopidine tablets 1, 2 times on the 1st; Halo (tamsulosin hydrochloride capsules) 1 capsule per night, each one. Results After 4 weeks of treatment, the total effective rate was 91.3%. No adverse effects of any drugs were found during the observation of the whole group of patients. Conclusion Senetife combined with Harlech treatment of chronic non-bacterial prostatitis curative effect is exact and well tolerated.